CCAAT/enhancer binding protein δ (C/EBPδ) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the C/EBPδ growth inhibitory pathway in breast cancer cell lines

Journal of Cellular Biochemistry

Volumn 93, Issue 4, 2004, Pages 830-843

  Sivko, G S ^a   DeWille, J W ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

CCAAT enhancer binding protein (C EBP ); Cytokine; Growth arrest; Mammary epithelial cells; Signal transducer and activator of transcription 3 (STAT3)

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CCAAT ENHANCER BINDING PROTEIN DELTA; INTERLEUKIN 6; ONCOSTATIN M; STAT3 PROTEIN; AKT1 PROTEIN, HUMAN; CCAAT ENHANCER BINDING PROTEIN; CEBPD PROTEIN, HUMAN; DNA BINDING PROTEIN; ONCOPROTEIN; OSM PROTEIN, HUMAN; PEPTIDE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; STAT3 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; ENZYME ACTIVATION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; BREAST TUMOR; CULTURE MEDIUM; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MAMMARY GLAND; METABOLISM; TUMOR CELL LINE;

BREAST NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; CULTURE MEDIA; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; MAMMARY GLANDS, HUMAN; ONCOSTATIN M; PEPTIDES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 21744440766     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20223     Document Type: Article

References (41)

1. Alam T, An MR, Papaconstantinou J. 1992. Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. J Biol Chem 267:5021-5024.
2. Barre B, Avril S, Coqueret O. 2003. Opposite regulation of myc and p21waf1 transcription by STAT3 proteins. J Biol Chem 278:2990-2996.
3. Beckmann MW, Niederacher D, Schnurch HG, Gusterson BA, Bender HG. 1997. Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med 75:429-439.
4. Cao Z, Umek RM, McKnight SL. 1991. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5:1538-1552.
5. Datta SR, Brunet A, Greenberg ME. 1999. Cellular survival: A play in three Akts. Genes Dev 13:2905-2927.
6. Downward J. 1998. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10:262-267.
7. Gigliotti AP, DeWille JW. 1998. Lactation status influences expression of CCAAT/enhancer binding protein isoform mRNA in the mouse mammary gland. J Cell Physiol 174: 232-239.
8. Gigliotti AP, DeWille JW. 1999. Local signals induce CCAAT/enhancer binding protein-delta (C/EBP-delta) and C/EBP-beta mRNA expression in the involuting mouse mammary gland. Breast Cancer Res Treat 58: 57-63.
9. Gigliotti AP, Johnson PF, Sterneck E, DeWille JW. 2003. Nulliparous CCAAT/enhancer binding proteindelta (C/ EBPdelta) knockout mice exhibit mammary gland ductal hyperlasia. Exp Biol Med (Maywood) 228:278-285.
10. Gombart AF, Hofmann WK, Kawano S, Takeuchi S, Krug U, Kwok SH, Larsen RJ, Asou H, Miller CW, Hoelzer D, Koeffler HP. 2002. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. Blood 99:1332-1340.
11. Greenlee RT, Murray T, Bolden S, Wingo PA. 2000. Cancer statistics, 2000. CA Cancer J Clin 50:7-33.
12. Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD, Tenen DG. 2002. Down-regulation and antiproliferative role of C/EBPalpha in lung cancer. Cancer Res 62:528-534.
13. Harris TE, Albrecht JH, Nakanishi M, Darlington GJ. 2001. CCAAT/enhancer-binding protein-alpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding. J Biol Chem 276:29200-29209.
14. Hurst HC. 1995. Transcription factors 1: bZIP proteins. Protein Profile 2:101-168.
15. Hutt JA, DeWille JW. 2002. Oncostatin M induces growth arrest of mammary epithelium via a CCAAT/enhancer-binding protein delta-dependent pathway. Mol Cancer Ther 1:601-610.
16. 0 growth-arrested mouse mammary epithelial cells and in involuting mouse mammary gland. J Biol Chem 275: 29123-29131.
17. Jung N, Yi YW, Kim D, Shong M, Hong SS, Lee HS, Bae I. 2000. Regulation of Gadd45gamma expression by C/EBP. Eur J Biochem 267:6180-6187.
18. Krasilnikov M, Ivanov VN, Dong J, Ronai Z. 2003. ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: Implications towards sensitization to apoptosis. Oncogene 22:4092-4101.
19. Lacroix M, Leclercq G. 2004. Relevance of breast cancer cell lines as models for breast tumours: An update. Breast Cancer Res Treat 83:249-289.
20. Lee TH, Chuang LY, Hung WC. 1999. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells. Oncogene 18:4269-4274.
21. Lekstrom-Himes J, Xanthopoulos KG. 1998. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 273:28545-28548.
22. Moudgil VK, Dinda S, Khattree N, Jhanwar S, Alban P, Hurd C. 2001. Hormonal regulation of tumor suppressor proteins in breast cancer cells. J Steroid Biochem Mol Biol 76:105-117.
23. Nicholson KM, Anderson NG. 2002. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14:381-395.
24. Nicholson KM, Streuli CH, Anderson NG. 2003. Autocrine signalling through erbB receptors promotes constitutive activation of protein kinase B/Akt in breast cancer cell lines. Breast Cancer Res Treat 81:117-128.
25. O'Rourke J, Yuan R, DeWille J. 1997. CCAAT/enhancer-binding protein-delta (C/EBP-delta) is induced in growth-arrested mouse mammary epithelial cells. J Biol Chem 272:6291-6296.
26. O'Rourke JP, Hutt JA, DeWille J. 1999a. Transcriptional regulation of C/EBPdelta in G(0) growth-arrested mouse mammary epithelial cells. Biochem Biophys Res Commun 262:696-701.
27. 0 growth arrest and apoptosis. J Biol Chem 274:16582-16589.
28. Paine TM, Soule HD, Pauley RJ, Dawson PJ. 1992. Characterization of epithelial phenotypes in mortal and immortal human breast cells. Int J Cancer 50:463-473.
29. Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, Riggins G, Polyak K. 2001. A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res 61:5697-5702.
30. Romanov SR, Kozakiewicz BK, Holst CR, Stampfer MR, Haupt LM, Tlsty TD. 2001. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 409:633-637.
31. Russo J, Russo IH. 2001. The pathway of neoplastic transformation of human breast epithelial cells. Radiat Res 155:151-154.
32. Soule HD, Maloney TM, Wolman SR, Peterson WD, Jr., Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6075-6086.
33. Stampfer MR, Bodnar A, Garbe J, Wong M, Pan A, Villeponteau B, Yaswen P. 1997. Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells. Mol Biol Cell 8:2391-2405.
34. 1 phase of the cell cycle. Eur J Cancer Clin Oncol 19:615-621.
35. Taylor CM, Blanchard B, Zava DT. 1984. Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen. Cancer Res 44: 1409-1414.
36. Tenen DG. 2001. Abnormalities of the CEBP alpha transcription factor: A major target in acute myeloid leukemia. Leukemia 15:688-689.
37. Yaswen P, Stampfer MR. 2001. Epigenetic changes accompanying human mammary epithelial cell immortalization. J Mammary Gland Biol Neoplasia 6:223-234.
38. Yaswen P, Stampfer MR. 2002. Molecular changes accompanying senescence and immortalization of cultured human mammary epithelial cells. Int J Biochem Cell Biol 34:1382-1394.
39. Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP, Johnson PH. 2001. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 61:5168-5178.
40. Zhang SY, Liu SC, Al Saleem LF, Holloran D, Babb J, Guo X, Klein-Szanto AJ. 2000. E2F-1: A proliferative marker of breast neoplasia. Cancer Epidemiol Biomarkers Prev 9:395-401.
41. Zhu S, Yoon K, Sterneck E, Johnson PF, Smart RC. 2002. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc Natl Acad Sci USA 99:207-212.